Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression. Journal Article

Authors: Drakes, ML; Stiff, PJ
Article Title: Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression.
Abstract: Ovarian cancer generally escapes diagnosis until the advanced stages. High-grade serous ovarian cancer (HGSOC) is the most frequently occurring form of this malaise and is a disease which has the highest mortality rate of gynecologic cancers. Over recent years it has been revealed that the course of such cancers can be significantly influenced by the nature of immune cells in tumors at the time of diagnosis and by immune cells induced by therapy. Numerous investigators have since focused on disease biology to identify biomarkers or therapeutic targets. Yet, while over the past decade there have been significant improvements in state-of-the-art surgery for ovarian cancer as frontline therapy, there have been limited advancements in the development of novel curative or management drugs for this disease. This chapter discusses the major elements of immune suppression in HGSOC from a biological viewpoint, mechanisms of overcoming resistance to therapies, and recent therapy aimed at improving patient care and survival.
Journal Title: Advances in Experimental Medicine and Biology
Publisher: Unknown  
Date Published: 2021
Related LUC Article